piracetam has been researched along with Angelman Syndrome in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Angelman Syndrome: A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence happy); jerky puppetlike movements (hence puppet); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the urgency to treat nonconvulsive status epilepticus depends on the underlying illness, most clinicians and authors agree that treatment should be focused to rapidly terminate this condition." | 5.36 | Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome. ( Weber, P, 2010) |
| "Although the urgency to treat nonconvulsive status epilepticus depends on the underlying illness, most clinicians and authors agree that treatment should be focused to rapidly terminate this condition." | 1.36 | Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome. ( Weber, P, 2010) |
| "Epilepsy was most common among those with maternal deletions and unknown subtypes, with catastrophic epilepsies present in only these two subtypes." | 1.35 | Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. ( Braun, EK; Bruno, P; Conant, KD; Nespeca, MP; Said, RR; Thibert, RL; Thiele, EA, 2009) |
| "Treatment with piracetam in 5 patients significantly improved myoclonus." | 1.29 | Cortical myoclonus in Angelman syndrome. ( Bonanni, P; Bureau, M; De Lorey, TM; Dravet, C; Genton, P; Guerrini, R; Livet, MO; Malzac, P; Moncla, A; Sartucci, F; Serratosa, JM; Simi, P; Suisse, G; Thomas, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thibert, RL | 1 |
| Conant, KD | 1 |
| Braun, EK | 1 |
| Bruno, P | 1 |
| Said, RR | 1 |
| Nespeca, MP | 1 |
| Thiele, EA | 1 |
| Weber, P | 1 |
| Guerrini, R | 1 |
| De Lorey, TM | 1 |
| Bonanni, P | 1 |
| Moncla, A | 1 |
| Dravet, C | 1 |
| Suisse, G | 1 |
| Livet, MO | 1 |
| Bureau, M | 1 |
| Malzac, P | 1 |
| Genton, P | 1 |
| Thomas, P | 1 |
| Sartucci, F | 1 |
| Simi, P | 1 |
| Serratosa, JM | 1 |
3 other studies available for piracetam and Angelman Syndrome
| Article | Year |
|---|---|
Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
Topics: Adolescent; Adult; Angelman Syndrome; Anticonvulsants; Child; Child, Preschool; Clonazepam; Comorbid | 2009 |
Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome.
Topics: Angelman Syndrome; Anticonvulsants; Brain; Child; Electroencephalography; Humans; Levetiracetam; Mal | 2010 |
Cortical myoclonus in Angelman syndrome.
Topics: Adolescent; Adult; Angelman Syndrome; Anticonvulsants; Cerebral Cortex; Child; Child, Preschool; Chr | 1996 |